California Retina Associates has Affiliated with Chavez Eye Care
The Partners of ShoreView are pleased to announce that California Retina Associates (“CRA”), a ShoreView portfolio company, has affiliated with Cesar Chavez, M.D., Inc. (“Chavez Eye Care”).
Founded in 1988, Chavez Eye Care is an ophthalmology and cataract surgery practice based in El Centro, California led by Dr. Cesar Chavez. A diplomate of the American Board of Ophthalmology and a Fellow of the American Academy of Ophthalmology, Dr. Chavez specializes in clear corneal, sutureless cataract surgery, glaucoma laser surgery, pterygium and eyelid surgery. The affiliation with Chavez Eye Care adds to CRA’s leadership position in Southern California.
CRA is one of the largest retina-focused eye care practices in Southern California and operates across three clinical sites and one ambulatory surgery center in San Diego and Imperial Counties. CRA’s specialist physicians provide a diverse range of treatments related to retina and vitreous diseases and other common eye diseases such as glaucoma and cataracts. In December 2018, ShoreView invested alongside the founders of CRA in an administrative services organization that provides administrative and non-clinical support services to CRA as well as other specialty eye care practices throughout the Western United States. CRA continues to seek to affiliate with other leading ophthalmology groups like Chavez Eye Care to grow its presence in contiguous regions.
ShoreView assisted CRA in its affiliation with Chavez Eye Care. To learn more about CRA, visit its website at http://www.retinadrs.com.
Founded in 2002, ShoreView is a Minneapolis-based private equity firm that has raised over $1.3 billion of committed capital across four funds. ShoreView partners with family or entrepreneurial-owned companies across many sectors, including engineered products, distribution, industrial services, business services, healthcare, and niche consumer products. ShoreView structures a variety of acquisition, recapitalization and build-up transactions, typically in businesses with revenues ranging between $20 million and $300 million.